Synovus Financial’s Merck MRK Stock Holding History

Synovus Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$21.5M	Sell	256,591 -2,141	-0.8%	-$176K	0.25%	64
2025 Q2	$20.5M	Sell	258,732 -468	-0.2%	-$37.2K	0.25%	62
2025 Q1	$23.3M	Sell	259,200 -4,784	-2%	-$447K	0.3%	50
2024 Q4	$26.3M	Sell	263,984 -60,997	-19%	-$6.29M	0.33%	44
2024 Q3	$36.9M	Buy	324,981 +26,449	+9%	+$3.14M	0.43%	37
2024 Q2	$37M	Sell	298,532 -6,962	-2%	-$897K	0.49%	30
2024 Q1	$40.3M	Buy	305,494 +969	+0.3%	+$119K	0.52%	28
2023 Q4	$33.2M	Sell	304,525 -100,839	-25%	-$10.5M	0.47%	30
2023 Q3	$41.7M	Sell	405,364 -14,195	-3%	-$1.53M	0.48%	40
2023 Q2	$48.4M	Buy	419,559 +277	+0.1%	+$31.5K	0.53%	35
2023 Q1	$44.6M	Sell	419,282 -3,134	-0.7%	-$338K	0.5%	40
2022 Q4	$46.9M	Buy	422,416 +4,597	+1%	+$470K	0.53%	34
2022 Q3	$36M	Buy	417,819 +11,105	+3%	+$991K	0.44%	40
2022 Q2	$37.1M	Buy	406,714 +19,440	+5%	+$1.72M	0.44%	38
2022 Q1	$31.7M	Sell	387,274 -43,708	-10%	-$3.45M	0.34%	42
2021 Q4	$33M	Buy	430,982 +35,513	+9%	+$2.83M	0.33%	44
2021 Q3	$29.8M	Sell	395,469 -21,204	-5%	-$1.61M	0.31%	45
2021 Q2	$32.4M	Sell	416,673 -34,460	-8%	-$2.56M	0.32%	43
2021 Q1	$33.2M	Buy	451,133 +11,934	+3%	+$880K	0.37%	36
2020 Q4	$34.2M	Buy	439,199 +14,805	+3%	+$1.13M	0.39%	35
2020 Q3	$33.6M	Sell	424,394 -10,505	-2%	-$823K	0.45%	33
2020 Q2	$32.1M	Sell	434,899 -82,258	-16%	-$6.19M	0.47%	35
2020 Q1	$38M	Buy	517,157 +110,809	+27%	+$8.71M	0.53%	35
2019 Q4	$35.3M	Sell	406,348 -773	-0.2%	-$63.5K	0.48%	35
2019 Q3	$32.7M	Buy	407,121 +12,471	+3%	+$999K	0.49%	34
2019 Q2	$31.6M	Sell	394,650 -9,725	-2%	-$745K	0.47%	34
2019 Q1	$32.1M	Sell	404,375 -2,209	-0.5%	-$165K	0.52%	35
2018 Q4	$29.6M	Sell	406,584 -57,422	-12%	-$4.05M	0.54%	34
2018 Q3	$31.4M	Sell	464,006 -12,659	-3%	-$806K	0.5%	33
2018 Q2	$27.6M	Buy	476,665 +5,244	+1%	+$296K	0.46%	37
2018 Q1	$24.5M	Buy	471,421 +7,405	+2%	+$400K	0.41%	39
2017 Q4	$24.9M	Buy	464,016 +19,261	+4%	+$1.07M	0.44%	34
2017 Q3	$27.2M	Buy	444,755 +8,868	+2%	+$538K	0.52%	30
2017 Q2	$26.6M	Buy	435,887 +24,941	+6%	+$1.52M	0.53%	31
2017 Q1	$24.9M	Buy	410,946 +12,604	+3%	+$765K	0.52%	32
2016 Q4	$22.4M	Buy	398,342 +6,746	+2%	+$395K	0.51%	32
2016 Q3	$23.3M	Sell	391,596 -7,758	-2%	-$454K	0.55%	31
2016 Q2	$22M	Buy	399,354 +6,112	+2%	+$325K	0.51%	34
2016 Q1	$19.9M	Buy	393,242 +17,255	+5%	+$845K	0.48%	34
2015 Q4	$18.9M	Buy	375,987 +7,919	+2%	+$399K	0.47%	38
2015 Q3	$17.3M	Buy	368,068 +962	+0.3%	+$51.1K	0.46%	36
2015 Q2	$20M	Buy	367,106 +378	+0.1%	+$21.2K	0.51%	34
2015 Q1	$20.1M	Buy	366,728 +18,263	+5%	+$1.03M	0.52%	34
2014 Q4	$18.9M	Sell	348,465 -1,671	-0.5%	-$93.1K	0.5%	35
2014 Q3	$19.8M	Sell	350,136 -6,023	-2%	-$338K	0.55%	34
2014 Q2	$19.7M	Buy	356,159 +1,054	+0.3%	+$57.5K	0.56%	33
2014 Q1	$19.2M	Buy	355,105 +6,173	+2%	+$320K	0.57%	32
2013 Q4	$16.7M	Buy	348,932 +7,075	+2%	+$323K	0.48%	39
2013 Q3	$15.6M	Sell	341,857 -11,413	-3%	-$521K	0.49%	38
2013 Q2	$15.7M	Buy	+353,270	New	+$15.8M	0.48%	38

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Synovus Financial's MRK Position: Q3 2025 in Review

Synovus Financial reduced its Merck (MRK) stake by 0.83% in Q3 2025, selling an estimated $176K and leaving 256,591 shares worth $21.5M. The position accounts for 0.25% of the portfolio, ranked #64.

Synovus Financial first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $48.4M in Q2 2023. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

Synovus Financial held 256,591 shares of Merck worth $21.5M as of Q3 2025.
Synovus Financial sold 2,141 Merck shares in Q3 2025, an estimated $176K.
Merck made up 0.25% of Synovus Financial's portfolio in Q3 2025, its #64 holding.
Synovus Financial first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
Synovus Financial's Merck position peaked at $48.4M in Q2 2023.
3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.